Carregant...
How Often Does Modern Neoadjuvant Chemotherapy (NAC) Downstage Patients to Breast-Conserving Surgery (BCS)?
BACKGROUND: NAC has been proven to increase BCS rates, but data are limited on conversion rates from BCS-ineligible (BCSi) to BCS-eligible (BCSe), specifically, in patients with large tumors. METHODS: Consecutive patients with stage I-III breast cancer treated with NAC from 11/2013–03/2019 were iden...
Guardat en:
| Publicat a: | Ann Surg Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7722183/ https://ncbi.nlm.nih.gov/pubmed/32514804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-020-08593-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|